RAPP
NASDAQ · Pharmaceuticals
Rapport Therapeutics Inc
$39.83
-0.17 (-0.43%)
Open$40.16
Previous Close$40.00
Day High$40.19
Day Low$39.76
52W High$42.27
52W Low$10.51
Volume—
Avg Volume335.6K
Market Cap1.79B
P/E Ratio—
EPS$-2.60
SectorPharmaceuticals
Analyst Ratings
Strong Buy
17 analysts
Price Target
+13.4% upside
Current
$39.83
$39.83
Target
$45.18
$45.18
$32.24
$45.18 avg
$61.72
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 234.18M | 211.21M | 206.84M |
| Net Income | 54.92M | 48.45M | 43.47M |
| Profit Margin | 23.5% | 22.9% | 21.0% |
| EBITDA | 80.71M | 80.88M | 78.48M |
| Free Cash Flow | 32.46M | 39.08M | 24.42M |
| Rev Growth | +10.7% | -0.4% | +18.1% |
| Debt/Equity | 0.72 | 0.64 | 0.71 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,124.85 | +0.68% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $245.14 | +1.72% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $124.71 | +3.41% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $23.83 | -0.87% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.00 | -0.95% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $77.65 | -0.67% | 12.5 | 33.00B |